Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
Clinical trial NCT03569007 · TERMINATED
Trial details
- NCT number
- NCT03569007
- Sponsor
- 9 Meters Biopharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2022-07-21
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.